Lund Melanoma Study Group
1 – 10 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Systemic and local decorin levels mirror the clinical course of pancreatic cancer
- Contribution to journal › Article
- 2025
-
Mark
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
- Contribution to journal › Article
-
Mark
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
- Contribution to journal › Article
-
Mark
Prognostic Differences of Adjuvant Radiotherapy in Breast Cancer Cohorts Based on PRLR Genotypes, Expression, and Transcriptional Network Regulation
- Contribution to journal › Article
-
Mark
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
- Contribution to journal › Article
-
Mark
Hypogammaglobulinemia at Diagnosis is Associated With Inferior Survival and Higher Risk of Infections in Diffuse Large B Cell Lymphoma
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
- Contribution to journal › Scientific review
-
Mark
Assessing differentiation in cutaneous squamous cell carcinoma : A machine learning approach
- Contribution to journal › Article
-
Mark
Septic arthritis score (SAS) - a novel clinical prediction model for the probability of septic arthritis in the adult native knee
- Contribution to journal › Article
-
Mark
Tattoos and cutaneous squamous cell carcinoma : a population-based case-control study
- Contribution to journal › Article
